Paenilamicins are context-specific translocation inhibitors of protein synthesis.

帕尼拉霉素是具有特定环境的蛋白质合成转位抑制剂

阅读:4
作者:Koller Timm O, Berger Max J, Morici Martino, Paternoga Helge, Bulatov Timur, Di Stasi Adriana, Dang Tam, Mainz Andi, Raulf Karoline, Crowe-McAuliffe Caillan, Scocchi Marco, Mardirossian Mario, Beckert Bertrand, Vázquez-Laslop Nora, Mankin Alexander S, Süssmuth Roderich D, Wilson Daniel N
The paenilamicins are a group of hybrid nonribosomal peptide-polyketide compounds produced by the honey bee pathogen Paenibacillus larvae that display activity against Gram-positive pathogens, such as Staphylococcus aureus. While paenilamicins have been shown to inhibit protein synthesis, their mechanism of action has remained unclear. Here we determine structures of paenilamicin PamB2-stalled ribosomes, revealing a unique binding site on the small 30S subunit located between the A- and P-site transfer RNAs (tRNAs). In addition to providing a precise description of interactions of PamB2 with the ribosome, the structures also rationalize the resistance mechanisms used by P. larvae. We further demonstrate that PamB2 interferes with the translocation of messenger RNA and tRNAs through the ribosome during translation elongation, and that this inhibitory activity is influenced by the presence of modifications at position 37 of the A-site tRNA. Collectively, our study defines the paenilamicins as a class of context-specific translocation inhibitors.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。